📰 Balance Analyzer News
Balance Analyzer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Balance Analyzer. Real-time updates on events, politics, business and more.
June 8, 2023
Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics Euronext Growth Paris ISIN: FR0014005I80 Ticker: ALSMA), a French player specializing in transforming vertebral
June 8, 2023
Software, Machines and Adaptative Implants in Orthopaedics recieved FDA 510(k) clearance for its custom surgery planning software developed with NuVasive.
April 11, 2023
2022 sales up +15% to €2.4 million driven by international business Significant improvement in the margin on cost of sales to 63% from 55% in 2021 thanks to an increased presence in high value-added
January 17, 2023
Strong growth of +60% in international sales Video interview: Philippe Roussouly, Chairman and CEO of SMAIO, discusses the Company's 2022 achievements and 2023 prospects Regulatory News:
September 27, 2022
First-half 2022 sales up +28% to €1.3 million Improvement in the sales margin thanks to better implant procurement conditions Exceptional income of +€7.4 million resulting from the dropping
July 12, 2022
First surgical procedures performed in the United States with the Kheiron system Two FDA 510(k) clearances to accelerate the distribution of the i-Kontrol solution on the North American market Regulatory
June 15, 2022
Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics Euronext Growth Paris ISIN: FR0014005I80 Ticker: ALSMA, eligible for PEA-PME equity savings plans) (Paris:ALSMA)
June 2, 2022
Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics Euronext Growth Paris ISIN: FR0014005I80 Ticker: ALSMA, eligible for PEA-PME equity savings plans), a French player